| scholarly article | Q13442814 |
| P2093 | author name string | H Zhu | |
| C Liu | |||
| Y Xu | |||
| D R Nelson | |||
| H-J Dong | |||
| E A Eksioglu | |||
| J Elyar | |||
| J R Bess | |||
| P2860 | cites work | Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 |
| Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain | Q24301056 | ||
| Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells | Q27472707 | ||
| Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. | Q27472875 | ||
| Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy | Q27478115 | ||
| Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C | Q27478117 | ||
| Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection | Q27478125 | ||
| Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses | Q27485419 | ||
| Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production | Q27485530 | ||
| Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells | Q27485559 | ||
| Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells | Q27488392 | ||
| Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection | Q44975291 | ||
| Hepatitis C virus E2 envelope protein induces dendritic cell maturation | Q45398763 | ||
| Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels | Q45423852 | ||
| Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection | Q45655822 | ||
| Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection | Q45737458 | ||
| Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors | Q56987977 | ||
| Dendritic cells at the host-pathogen interface | Q57265339 | ||
| Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha | Q73751701 | ||
| [Dendritic cells and hepatitis C virus] | Q74309804 | ||
| [Function of dendritic cell in chronic hepatitis C patients] | Q74498744 | ||
| Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C | Q81922494 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| [Acceleration of mixed lymphocyte reaction by HCV C-Fc gene-transferred murine dendritic cells]. | Q31078225 | ||
| Dendritic cell vaccines for cancer immunotherapy | Q33540299 | ||
| Origin and differentiation of dendritic cells | Q34460711 | ||
| Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection | Q34595346 | ||
| Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor | Q34605812 | ||
| Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy | Q35635696 | ||
| Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus | Q35784239 | ||
| Dendritic cells as therapeutic vaccines against cancer | Q36085614 | ||
| Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity | Q36099441 | ||
| Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? | Q36108089 | ||
| Drug abuse, innate immunity and hepatitis C virus | Q36577777 | ||
| Impact of alpha interferon and ribavirin on the function of maturing dendritic cells | Q39954409 | ||
| Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein. | Q40070362 | ||
| Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities | Q40339035 | ||
| Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. | Q40515590 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. | Q42167578 | ||
| Hepatitis C virus structural proteins do not prevent human dendritic cell maturation | Q42977198 | ||
| GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation | Q42978356 | ||
| Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells | Q42978974 | ||
| Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment | Q42980351 | ||
| Presence of functional dendritic cells in patients chronically infected with hepatitis C virus | Q42980525 | ||
| Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity | Q42982625 | ||
| Uptake and presentation of hepatitis C virus-like particles by human dendritic cells | Q42990053 | ||
| Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals | Q42993342 | ||
| An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity | Q42996577 | ||
| Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. | Q42997168 | ||
| Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma | Q42999457 | ||
| Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection | Q43001795 | ||
| Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients | Q43031528 | ||
| Do DCs influence the antiviral effect of interferon/ribavirin by changing their profile during the therapy? | Q43031543 | ||
| Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. | Q43033205 | ||
| Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro | Q43033779 | ||
| TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection | Q43036590 | ||
| Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection | Q43037738 | ||
| Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells | Q43040621 | ||
| Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function | Q43048332 | ||
| Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. | Q43048494 | ||
| Significance of alterations in PBMC immunophenotype of children with chronic viral hepatitis C-- the role of dendritic cells | Q44156739 | ||
| Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines | Q44190727 | ||
| The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C. | Q44648965 | ||
| Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection | Q44736670 | ||
| P433 | issue | 11 | |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 757-769 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Hepatitis C virus modulates human monocyte-derived dendritic cells | |
| P478 | volume | 17 |
| Q33939184 | Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells. |
| Q34305417 | DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response |
| Q37843841 | Dendritic cells in hepatitis C infection: can they (help) win the battle? |
| Q34341382 | Innate immune cell networking in hepatitis C virus infection |
| Q39044242 | Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy |
| Q27491033 | Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells |
Search more.